HCC Risk (AFP+PIVKA-II+ASAP formula)
This test measures AFP and PIVKA-II to screen for liver cancer, potentially improving early detection and risk assessment, especially for chronic hepatitis B or C patients.
- The description claims this test can improve early detection and risk assessment.
AI Readiness
Good foundation, but some important product data is still missing.
65%